C-Reactive Protein as a Predictor for Airway Hyper-Responsiveness

Asthma Clinical Trial

Official title:

C-Reactive Protein as a Predictor for Airway Hyper-responsiveness

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01002144
• Other study ID #: CRPAHR - CTIL
• Status: Completed
• Phase: N/A
• First received: September 30, 2009
• Last updated: October 26, 2009
• Start date: March 2007
• Est. completion date: May 2009

Study information

• Verified date: October 2009
• Source: Rambam Health Care Campus
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Background: Increased serum high sensitivity C-reactive protein (hs-CRP) has been associated with airway inflammation in asthma and may serve as a surrogate marker for the presence of airway hyper-responsiveness (AHR) in this set-up. This study was designed to evaluate the predictive value of hs-CRP for AHR assessed by metacholine challenge test (MCT), in adults with suspected Asthma.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 88
• Est. completion date: May 2009
• Est. primary completion date: March 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• subjects that were referred to Metacholine challenge test

Exclusion Criteria:

• age < 18

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Asthma
• Respiratory Hypersensitivity

Intervention

Other:
• blood sampling

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Rambam Health Care Campus